Clinical Trials Browser

NIH × Carcinoma, Renal Cell × aflibercept × Clear all

NCT02298959 2026-03-19

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Phase 1 Active not recruiting

DermatologicGastrointestinalGenitourinaryGynecologicSarcoma

Carcinoma, Renal Cell, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms

NCT00357760 2017-06-23

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Completed

94 enrolled 8 charts

Carcinoma, Renal Cell